Back to search

Article

Development and validation of a multiple factor-based prognostic score system of thrombosis in polycythemia vera (MFPS-PV)

2022-05-13

Abstract excerpt

Thrombosis is an important cause of death in patients with polycythemia vera (PV). This study aimed to develop and validate a multiple factor-based prediction model of thrombosis and to propose risk-adapted treatment strategies for the 2016 World Health Organization-defined PV. The study involved 301 patients in the training cohort and another 194 patients in the external validation cohort. Multivariate analysis i...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
52e75914-3ca5-55cd-9ac9-7a965f70741d
DOI
10.21203/rs.3.rs-1630456/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Development and validation of a multiple factor-based prognostic score system of thrombosis in polycythemia vera (MFPS-PV)DOI 10.21203/rs.3.rs-1630456/v1
[Analysis of risk factors for venous thromboembolism in patients with polycythemia vera and establishment of a prediction model].Semantic proximity
Prognostic risk model for patients with high-risk polycythemia vera and essential thrombocythemia.Semantic proximity
Thrombosis-Driven Disease Progression in JAK2-Mutant Polycythemia Vera and Essential Thrombocythemia: Reassessing Risk-Based Management.Semantic proximity
Facilitating clinical trials in Polycythemia vera (PV) by identifying patient cohorts at high near-term risk of thrombosis using rich data and machine learningSemantic proximity
New and treatment-relevant risk stratification for thrombosis in essential thrombocythemia and polycythemia vera.Semantic proximity
Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management.Semantic proximity
Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk-stratification, and management.Semantic proximity
Validation of the revised International Prognostic Score of Thrombosis for Essential Thrombocythemia (IPSET-thrombosis) in 585 Mayo Clinic patients.Semantic proximity
Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk-stratification and management.Semantic proximity
Impact of ELN clinical signs and symptoms on the thrombotic risk in Polycythemia Vera patients treated with front-line hydroxyureaSemantic proximity
It is time to change thrombosis risk assessment for PV and ET?Semantic proximity
DNMT3A/TET2/ASXL1 Mutations are an Age-independent Thrombotic Risk Factor in Polycythemia Vera Patients: An Observational Study.Semantic proximity
Select a neighboring publication to make it the new centre.